Statins may not protect against vasospasm in subarachnoid haemorrhage

Journal of Clinical Neuroscience

Volumn 16, Issue 4, 2009, Pages 527-530

  Kern, Michael ^a   Lam, Mark M F ^a   Knuckey, Neville W ^a,b   Lind, Christopher R P ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Doppler; Pravastatin; Statins; Subarachnoid hemorrhage; Transcranial; Ultrasonography; Vasospasm

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ADULT; ANGIOGRAPHY; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN BLOOD FLOW; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RISK FACTOR; STATISTICAL SIGNIFICANCE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM;

FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PRAVASTATIN; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOSPASM, INTRACRANIAL;

EID: 61449122908     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.08.001     Document Type: Article

References (23)

1. Khurana V.G., Smith L.A., Baker T.A., et al. Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke 33 (2002) 782-789
2. Pluta R.M. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Neurol Res 28 (2006) 730-737
3. Suhardja A. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage. Nature Clin Pract Cardiovasc Med 1 (2004) 110-116
4. Endres M., Laufs U., Huang Z., et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95 (1998) 8880-8885
5. Delanty N., and Vaughan C.J. Vascular effects of statins in stroke. Stroke 28 (1997) 2315-2320
6. Paciaroni M., Hennerici M., Agnelli G., et al. Statins and stroke prevention. Cerebrovasc Diseases 24 (2007) 170-182
7. Gertz K., Laufs U., Lindauer U., et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 34 (2003) 551-557
8. McGirt M.J., Lynch J.R., Parra A., et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33 (2002) 2950-2956
9. McGirt M.J., Pradilla G., Legnani F.G., et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 58 (2006) 945-951
10. McGirt M.J., Woodworth G.F., Pradilla G., et al. Galbraith Award: simvastatin attenuates experimental cerebral vasospasm and ameliorates serum markers of neuronal and endothelial injury in patients after subarachnoid hemorrhage: a dose-response effect dependent on endothelial nitric oxide synthase. Clin Neurosurg 52 (2005) 371-378
11. McGirt M.J., Blessing R., Alexander M.J., et al. Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. J Neurosurg 105 (2006) 671-674
12. Parra A., Kreiter K.T., Williams S., et al. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 56 (2005) 476-484
13. Singhal A.B., Topcuoglu M.A., Dorer D.J., et al. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64 (2005) 1008-1013
14. Tseng M.Y., Czosnyka M., Richards H., et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36 (2005) 1627-1632
15. Lynch J.R., Wang H., McGirt M.J., et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 36 (2005) 2024-2026
16. Roberts C.G., Guallar E., and Rodriguez A. Efficacy and safety of statin monotherapy in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci 62 (2007) 879-887
17. Bonita R., and Beaglehole R. Recovery of motor function after stroke. Stroke 19 (1988) 1497-1500
18. Lindegaard K.F., Nornes H., Bakke S.J., et al. Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl 42 (1988) 81-84
19. Aaslid R., Huber P., and Nornes H. A transcranial Doppler method in the evaluation of cerebrovascular spasm. Neuroradiology 28 (1986) 11-16
20. Tseng M.Y., Hutchinson P.J., Turner C.L., et al. Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial. J Neurosurg 107 (2007) 1092-1100
21. Tseng M.Y., Hutchinson P.J., Czosnyka M., et al. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 38 (2007) 1545-1550
22. Current Controlled Trials. meta Register of Controlled Trials (m RCT). http://www.controlled-trials.com/mrct/search.html. Accessed 1 July 2008.
23. Kramer A.H., Gurka M.J., Nathan B., et al. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery 62 (2008) 422-427